COVID-19 Update: Information and resources can be found here.

Side effects are not necessarily a bad thing

A new study by researchers in UT Southwestern's Kidney Cancer Program found that an autoimmune side effect of immune checkpoint inhibitor drugs could signal improved control of renal cell carcinoma (RCC), the most common type of kidney cancer. Pathology's Drs. Payal Kapur and Qi Cai contributed to this study.

See the full article about the study here.